Alexander Eggermont

1992–2026 年に発表

86
論文数
27,720
被引用数
75
h 指数
83
i10 指数

被引用数

Alexander Eggermont の年別被引用数1985 年: 被引用 1 件1994 年: 被引用 3 件1995 年: 被引用 3 件1997 年: 被引用 2 件1999 年: 被引用 7 件2000 年: 被引用 16 件2001 年: 被引用 11 件2002 年: 被引用 14 件2003 年: 被引用 21 件2004 年: 被引用 18 件2005 年: 被引用 36 件2006 年: 被引用 19 件2007 年: 被引用 26 件2008 年: 被引用 21 件2009 年: 被引用 28 件2010 年: 被引用 37 件2011 年: 被引用 45 件2012 年: 被引用 122 件2013 年: 被引用 214 件2014 年: 被引用 260 件2015 年: 被引用 336 件2016 年: 被引用 339 件2017 年: 被引用 387 件2018 年: 被引用 575 件2019 年: 被引用 1,297 件2020 年: 被引用 1,725 件2021 年: 被引用 1,710 件2022 年: 被引用 1,527 件2023 年: 被引用 1,200 件2024 年: 被引用 1,577 件2025 年: 被引用 898 件2026 年: 被引用 41 件1986〜1993 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,318 件、この内訳の 20.5%中国: 引用元論文 2,891 件、この内訳の 17.9%フランス: 引用元論文 914 件、この内訳の 5.7%イタリア: 引用元論文 867 件、この内訳の 5.4%イギリス: 引用元論文 757 件、この内訳の 4.7%ドイツ: 引用元論文 697 件、この内訳の 4.3%カナダ: 引用元論文 484 件、この内訳の 3%オランダ: 引用元論文 445 件、この内訳の 2.7%オーストラリア: 引用元論文 432 件、この内訳の 2.7%スペイン: 引用元論文 399 件、この内訳の 2.5%日本: 引用元論文 369 件、この内訳の 2.3%インド: 引用元論文 307 件、この内訳の 1.9%
0%20.5%その他 26.4%

分野

  • Medicine41.3%
  • Biochemistry, Genetics and Molecular Biology36.7%
  • Immunology and Microbiology14.5%
  • Engineering2.1%
  • Materials Science1.2%
  • Neuroscience0.9%
  • その他3.3%

トピック

  • Cancer Immunotherapy and Biomarkers10.1%
  • Gut microbiota and health7.8%
  • Immunotherapy and Immune Responses5.9%
  • Immune Cell Function and Interaction3.6%
  • CAR-T cell therapy research3%
  • Immune cells in cancer2.9%
  • その他66.7%

共著者

全論文

検索で開く
  1. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Benoît Quinquis, Nicolas Pons, Bernhard Ryffel, Véronique Minard-Colin, Patrick Gonin, Jean‐Charles Soria, Éric Deutsch, Yohann Loriot, François Ghiringhelli, Gérard Zalcman, François Goldwasser, Bernard Escudier, Matthew D. Hellmann, Alexander Eggermont, Didier Raoult, Laurence Albigès, Guido Kroemer, Laurence Zitvogel - Science 2017 被引用: 5,594

  2. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Caroline Robert, Christina Mateus, Guido Kroemer, Didier Raoult, Ivo G. Boneca, Franck Carbonnel, Mathias Chamaillard, Laurence Zitvogel - Science 2015 被引用: 3,456

  3. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

    著者: , , , , , - Annals of Oncology 2016 被引用: 1,372

  4. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip Rosenstiel, Didier Raoult, Vincent Cattoir, Ivo G. Boneca, Mathias Chamaillard, Laurence Zitvogel - Immunity 2016 被引用: 854

  5. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - OncoImmunology 2015 被引用: 782

  6. Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vichnou Poirier-Colame, Suzette Delaloge, Frédérique Penault‐Llorca, Sylvain Ladoire, Laurent Arnould, Joanna Cyrta, Marie-Charlotte Dessoliers, Alexander Eggermont, Marco E. Bianchi, Mikaël J. Pittet, Camilla Engblom, Christina Pfirschke, Xavier Préville, Gilles Uzé, Robert D. Schreiber, Melvyn T. Chow, Mark J. Smyth, Enrico Proietti, Fabrice André, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2014 被引用: 1,031

  7. Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Edoardo Pasolli, Nicola Segata, Carlos López-Otı́n, Zoltán Szállási, Fabrice André, Valerio Iebba, Valentin Quiniou, David Klatzmann, Jacques Bou Khalil, S. Khelaifia, Didier Raoult, Laurence Albigès, Bernard Escudier, Alexander Eggermont, Fathia Mami‐Chouaib, Paola Nisticò, François Ghiringhelli, Bertrand Routy, Nathalie Labarrière, Vincent Cattoir, Guido Kroemer, Laurence Zitvogel - Science 2020 被引用: 384

  8. Dendritic cell–derived exosomes for cancer therapy

    著者: , , , , , , - Journal of Clinical Investigation 2016 被引用: 613

  9. Global cancer surgery: delivering safe, affordable, and timely cancer surgery

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luiz Antônio Santini, Shailesh V. Shrikhande, Mark G. Shrime, Robert Thomas, Audrey Tieko Tsunoda, Cornelis J.�H. van de Velde, Umberto Veronesi, D. K. Vijaykumar, David Watters, Shan Wang, Yi‐Long Wu, Moez Zeiton, Arnie Purushotham - The Lancet Oncology 2015 被引用: 685

  10. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Caroline Robert, Alex Menzies, Thierry Lesimple, Michele Maio, Gerald P. Linette, Michael P. Brown, Peter Hersey, Inge Marie Svane, Laurent Mortier, Jacob Schachter, Catherine Barrow, Ragini R. Kudchadkar, Xinni Song, Caroline Dutriaux, Pietro Quaglino, Friedegund Meier, Paola Queirolo, Daniil Stroyakovskiy, Lars Bastholt, B. Guillot, Claus Garbe, Pablo L. Ortiz‐Romero, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Jean‐Philippe Arnault, Philippe Saïag, Carmen Loquai, Frank Meiß, Jan‐Christoph Simon, Gil Bar‐Sela, Vanna Chiarion‐Sileni, Bernard M. Fitzharris, Mike McCrystal, Phillip Parente, Jean‐François Baurain, P. Combemale, Célèste Lebbé, Axel Hauschild, Naoya Yamazaki, Reinhard Dummer, Mohammed Milhem, Marcin Dzienis, John Walker, L. Geoffrois, M.‐T. Leccia, Lutz Kretschmer, Daniel Hendler, Michal Lotem, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Elaine Dunwoodie, Christoph Höeller, L. Machet, Jessica C. Hassel, Geke A.P. Hospers, Maria-Jose Passos, Max Levin, Martin Fehr, Philippa Corrie, Ashita Waterston, Sigrun Hallmeyer, Henrik Schmidt, V. Descamps, J.‐P. Lacour, Carola Berking, Felix Kiecker, Pier Francesco Ferrucci ほか 32 名 - The Lancet Oncology 2021 被引用: 389

  11. Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2019 被引用: 590

  12. Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincenzo Bronte, Jennifer A. Wargo, Laurence Zitvogel - Cell Research 2019 被引用: 248

  13. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Yves Scoazec, Peggy Dartigues, Antoine Hollebecque, David Malka, Franck Pagès, Jérôme Galon, Ivo G. Boneca, Patricia Lepage, Bernard Ryffel, Didier Raoult, Alexander Eggermont, Tom Vanden Berghe, François Ghiringhelli, Peter Vandenabeele, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2020 被引用: 196

  14. Trial watch: IDO inhibitors in cancer therapy

    著者: , , , , , , , , , - OncoImmunology 2014 被引用: 325

  15. Classification of current anticancer immunotherapies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jérôme Galon, Abhishek D. Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Paweł Kaliński, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, J P Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J.M. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, A. Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer A. Rizvi, Catherine Sautès‐Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva‐Santos, Mark J. Smyth, Daniel E. Speiser, Radek Špíšek, Pramod K. Srivastava, James E. Talmadge, Éric Tartour, Sjoerd H. van der Burg, Benoı̂t J. Van den Eynde, Richard G. Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou, Guido Kroemer - Oncotarget 2014 被引用: 470

  16. Delivering affordable cancer care in high-income countries

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Catchpole, David Taylor, Jan Geißler, Nancy Brinker, David Meltzer, David Kerr, Matti Aapro - The Lancet Oncology 2011 被引用: 714

  17. Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

    著者: , , , , , , , , , , , , , - OncoImmunology 2015 被引用: 297

  18. Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy

    著者: , , , , , , , , - OncoImmunology 2012 被引用: 245

  19. Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thierry de Baère, Lambros Tselikas, Éric Solary, Eric Angevin, Alexander Eggermont, Fabrice André, Christophe Massard, Ken A. Olaussen, Jean‐Charles Soria, Benjamin Besse, Luc Friboulet - Clinical Cancer Research 2019 被引用: 167

  20. Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2024 被引用: 29

  21. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Haritha Vallabhaneni, Weihang Chai, Paola Minghetti, Cristina Pellegrini, Sarangan Ravichandran, Alexander Eggermont, Mark Lathrop, Ketty Peris, Giovanna Bianchi‐Scarrà, G Landi, Sharon A. Savage, Joshua N. Sampson, Ji He, Meredith Yeager, Lynn R. Goldin, Florence Démenais, Stephen J. Chanock, Margaret A. Tucker, Alisa M. Goldstein, Yie Liu, Maria Teresa Landi - Nature Genetics 2014 被引用: 333

  22. Predictors of responses to immune checkpoint blockade in advanced melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dirk Schadendorf, Ignacio Melero, Brigitte Dréno, Amir Khammari, Reinhard Dummer, Mitchell P. Levesque, Yoshinobu Koguchi, Lawrence Fong, Michal Lotem, Michal Baniyash, Henrik Schmidt, Inge Marie Svane, Guido Kroemer, Aurélien Marabelle, Stefan Michiels, Andréa Cavalcanti, Mark J. Smyth, Jeffrey S. Weber, Alexander Eggermont, Laurence Zitvogel - Nature Communications 2017 被引用: 201

  23. Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel–Lindau Gene Mutation Status

    著者: , , , , , , , , , , , , , , , , , , - European Urology 2015 被引用: 176

  24. Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review

    著者: , , , , , , , , , , , , - The Lancet Oncology 2019 被引用: 129